ETRA — Electra Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 2088082 ·
Last close
$8.35
Market Cap
$524.10M
52W High
$15.50
52W Low
$6.87
ADV30
391,213
Next earnings
—
Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company develops therapies that targets signal regulatory proteins for the treatment of novel targets for treatment of immune-mediated diseases and cancer. Its lead product candidate is ipsoprubart, that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, treatment for secondary hemophagocytic lymphohistiocytosis and T/NK Cell Malignancies; ELA822, a novel SIRP-specific monoclonal antibody for deplete activated T cells, treatment for T cell mediated immune disorders. Electra Therapeutics, Inc. was incorporated in 2018 and is based in South San Francisco, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 106,498,000 66,507,000 133,268,000
Dec 2025 — — — — 99,368,000 33,008,000 129,694,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-221,890,000
Inventory
—
Receivables
$264,000
ST Investments
$31,218,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
5

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -61,889,000 -61,975,000 99,368,000 129,694,000 -30,326,000 -60,484,000
Dec 2024 0 -26,317,000 -24,786,000 19,420,000 122,681,000 -103,261,000 -26,003,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.80

Peers — same industry

TickerNameMarket CapLastDaily %
ENTX Entera Bio Ltd. $521.77M $3.00 —
VALN Valneva SE $527.69M $5.57 —
SANA Sana Biotechnology, Inc. $563.31M $1.88 —
SRZN Surrozen, Inc./DE $571.47M $29.98 —
FENC FENNEC PHARMACEUTICALS INC. $479.44M $13.58 —

News headlines (Yahoo Finance, 1h cache)

Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights
2026-11-12 21:01 · Yahoo
Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London
2026-11-04 13:00 · Yahoo
Oura Shows How Shaky the IPO Market Really Is
2026-09-30 12:23 · Yahoo
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
2026-09-18 00:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.